FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

24111811000001104: Mirvaso 3mg/g gel (Galderma (UK) Ltd) 30 gram (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 30-Apr 2014. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
78947401000001110 Mirvaso 3mg/g gel (Galderma (UK) Ltd) 30 gram (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
78947501000001114 Mirvaso 3mg/g gel (Galderma (UK) Ltd) 30 gram en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Mirvaso 3mg/g gel (Galderma (UK) Ltd) 30 gram Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Mirvaso 3mg/g gel (Galderma (UK) Ltd) 30 gram Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Mirvaso 3mg/g gel (Galderma (UK) Ltd) 30 gram Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Mirvaso 3mg/g gel (Galderma (UK) Ltd) 30 gram Is a Generic Mirvaso gel 30 gram true Inferred relationship Existential restriction modifier
Mirvaso 3mg/g gel (Galderma (UK) Ltd) 30 gram Has AMP Mirvaso 3mg/g gel (Galderma (UK) Ltd) true Inferred relationship Existential restriction modifier
Mirvaso 3mg/g gel (Galderma (UK) Ltd) 30 gram Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Mirvaso 3mg/g gel (Galderma (UK) Ltd) 30 gram Has excipient Hydroxybenzoates false Inferred relationship Existential restriction modifier
Mirvaso 3mg/g gel (Galderma (UK) Ltd) 30 gram VMP prescribing status (attribute) Never valid to prescribe as a VMP false Inferred relationship Existential restriction modifier
Mirvaso 3mg/g gel (Galderma (UK) Ltd) 30 gram VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Mirvaso 3mg/g gel (Galderma (UK) Ltd) 30 gram Has specific active ingredient Brimonidine tartrate true Inferred relationship Existential restriction modifier
Mirvaso 3mg/g gel (Galderma (UK) Ltd) 30 gram Has dispensed dose form Gel true Inferred relationship Existential restriction modifier
Mirvaso 3mg/g gel (Galderma (UK) Ltd) 30 gram Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Mirvaso 3mg/g gel (Galderma (UK) Ltd) 30 gram Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Mirvaso 3mg/g gel (Galderma (UK) Ltd) 30 gram Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Mirvaso 3mg/g gel (Galderma (UK) Ltd) 30 gram Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Brimonidine true Inferred relationship Existential restriction modifier
Mirvaso 3mg/g gel (Galderma (UK) Ltd) 30 gram VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Mirvaso 3mg/g gel (Galderma (UK) Ltd) 30 gram Has basis of strength substance Brimonidine true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start